The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1517
Exablate Neuro for Essential Tremor
The full article is available to subscribers Subscriber Login   

The FDA has approved use of Exablate Neuro (Insightec) for unilateral thalamotomy to treat medication-refractory essential tremor in patients ≥22 years old. Exablate Neuro uses magnetic resonance-guided focused ultrasound (MRgFUS) to create lesions in the ventral intermediate nucleus of the thalamus. MRgFUS is also approved in the US for treatment of uterine fibroids and for pain palliation of bone metastases.

TREATMENT OF ESSENTIAL TREMOR — Essential tremor is a common neurological disorder that causes involuntary and rhythmic shaking, especially of the hand, head, neck, and voice. The tremor is not life threatening, but it can be distressing and make performance of everyday activities difficult. The most effective drugs used to treat essential tremor are the beta blocker propranolol (Inderal, and others) and (off-label) the anticonvulsant primidone (Mysoline, and generics); they ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Immediate Online access to current issue and archives from 1988 to the present
  • Mobile access to our mobile site and free apps for iOS, Android and Kindle
  • FREE online per issue CME/CE
Free trial offer
3 Free Issues of The Medical Letter on Drugs and Therapeutics mailed to your home or office PLUS online access.
Try a Free Trial Subscription
Purchase this article:
Title: Exablate Neuro for Essential Tremor
Article code: 1517c
 Electronic, downloadable article - $25